The Latest
-
Eli Lilly CEO Talks Coronavirus Treatment Progress: ‘This Is An Important Bridge Therapy’
-
How to value the big four ASX banks
-
Canopy Growth: Things Are Worse Than Thought, Says Jefferies
-
Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates